Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
New studies of old dogs help scientists understand where they came from - 2Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- 3Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- 47 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
- 5Nine in 10 German industrial firms expect Iran war to hit business
- Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Artemis II astronauts arrive at Florida launch site for first moon trip in 53 years
- Timex Gives Its Classic Affordable Field Watch a Tactical, Milspec Makeover
- Which One Energizes You the Most These Tech Developments
- Paraplegic engineer becomes the first wheelchair user to blast into space
- NATO official says members often aren't buying weapons together, and it's a mistake
- Amplifying Cash The executives: The Upsides and downsides of Various Ledgers
- This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
